Revolutionizing Nonunion Treatment: The Expanding Role of Local Biological Therapies
Kiwan E., Ghanem W., Ezzeddine H., Saber A., Najjar J., Saadeh J.
Laboratory Study, published in Orthop Rev (Pavia) (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Orthop Rev (Pavia) (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40589721
- PMCID
- PMC12208726
- DOI
- 10.52965/001c.141405
- Citations
- 3
Abstract (original English)
The diagnosis and treatment of long bone nonunion remains a historical challenge in the field of orthopedics. Bone nonunion management encompasses surgical and non-surgical options. This review discusses the potential use of untraditional methods in their treatment such as orthobiologics. The cornerstone of local biological therapies lies in their ability to directly stimulate the biological processes essential for bone repair. This precision targeting ensures that bone healing pathways are activated specifically where needed, enhancing both the rate and quality of union. It particularly addresses the use of biologic agents and the possibility of their combination with biomaterials to enhance their stability, delivery, and osteoconductive properties. The aim of this review is to obtain an updated point of view regarding the management of nonunion of the bone as well as expanding on the latest innovations aiming to create a shift from passive biologic supplementation to active regenerative engineering.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.